At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $1.77B, above the global median of $1.14B
- FinancialsAltman Z-Score 3.45: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.60BEUR1.77B · vs all stocks (USD)
Revenue (TTM)
3.22BEUR3.57B · vs all stocks (USD)
Profit Margin
-1.31%vs Pharmaceutical Retailers peers
Beta
1.31xvs all stocks
52-Week Change
10.38%vs all stocks
Forward Annual Dividend Yield
0.00%vs all stocks
Market Capitalization
1.60BEUR1.77B · vs all stocks (USD)
Enterprise Value
1.86BEUR2.06B · vs all stocks (USD)
Forward P/E
52.06xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
0.4889xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
3.51xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.5770xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
98.81xvs Pharmaceutical Retailers peers
Gross Margin
22.10%vs Pharmaceutical Retailers peers
Profit Margin
-1.31%vs Pharmaceutical Retailers peers
Operating Margin
1.43%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
-0.16%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
-8.67%vs Pharmaceutical Retailers peers
Revenue (TTM)
3.22BEUR3.57B · vs all stocks (USD)
Revenue per Share (TTM)
159.97EURUpdated Oct 29, 2026Quarterly Revenue Growth
20.30%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
693.70MEUR769.00M · vs all stocks (USD)
EBITDA (TTM)
48.10MEUR53.32M · vs all stocks (USD)
Net Income (TTM)
-42.00MEUR-46.56M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-49.50%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
-5.70MEUR-6.32M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-115.86MEUR-128.44M · vs all stocks (USD)
Forward Annual Dividend Yield
0.00%vs all stocks
Trailing Annual Dividend Rate
0.00EURUpdated Oct 29, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Minority Interest (Equity)
20.00MEURFY2025 · Dec 31, 2025Revenue
2.94BEURFY2025 · Dec 31, 2025Cost of Goods Sold
2.28BEURFY2025 · Dec 31, 2025Gross Profit
663.10MEURFY2025 · Dec 31, 2025Operating Income
-29.80MEUR-33.03M · vs all stocks (USD)
Pre-tax Income
-47.70MEURFY2025 · Dec 31, 2025Income Tax Expense
-8.30MEURFY2025 · Dec 31, 2025Net Income
-39.40MEURFY2025 · Dec 31, 2025EBIT
-27.80MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
48.10MEURFY2025 · Dec 31, 2025Selling, General & Administrative
427.10MEURFY2025 · Dec 31, 2025Other Operating Expenses
1.30MEURFY2025 · Dec 31, 2025Non-operating Interest Income
4.40MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
19.90MEURFY2025 · Dec 31, 2025EPS (Basic)
-1.87EURFY2025 · Dec 31, 2025EPS (Diluted)
-1.87EURFY2025 · Dec 31, 2025Basic Shares Outstanding
20.11MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
20.11MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-28.50MEURFY2025 · Dec 31, 2025Minority Interests (P&L)
1.70MEURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
-113.20MEURFY2025 · Dec 31, 2025Free Cash Flow
-192.50MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
92.40MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-28.50MEURFY2025 · Dec 31, 2025Stock-based Compensation
3.50MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-18.90MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-69.30MEURFY2025 · Dec 31, 2025Capital Expenditures
-79.30MEURFY2025 · Dec 31, 2025Net Intangibles (CF)
-39.30MEURFY2025 · Dec 31, 2025Net Acquisitions
0.00EURFY2025 · Dec 31, 2025Purchase of Investments
-32.80MEURFY2025 · Dec 31, 2025Sale of Investments
0.00EURFY2025 · Dec 31, 2025Net Investing Cash Flow
-112.10MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
296.30MEURFY2025 · Dec 31, 2025Long-term Debt Payments
-158.70MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
138.00MEURFY2025 · Dec 31, 2025Shares Outstanding
20.18MSharesUpdated Oct 29, 2026Float Shares
19.65MSharesUpdated Oct 29, 2026% Held by Insiders
18.70%vs all stocks
% Held by Institutions
36.30%vs all stocks
Total Cash (MRQ)
118.90MEUR131.81M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.78EURUpdated Oct 29, 2026Total Debt (MRQ)
354.70MEUR393.20M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.7466xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.58xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
22.22EURUpdated Oct 29, 2026Total Assets
1.21BEUR1.35B · vs all stocks (USD)
Total Current Assets
619.40MEURFY2025 · Dec 31, 2025Total Liabilities
735.10MEURFY2025 · Dec 31, 2025Total Non-current Assets
594.90MEURFY2025 · Dec 31, 2025Total Non-current Liabilities
335.10MEURFY2025 · Dec 31, 2025Total Current Liabilities
400.00MEURFY2025 · Dec 31, 2025Cash
92.10MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
92.10MEURFY2025 · Dec 31, 2025Other Short-term Investments
111.10MEURFY2025 · Dec 31, 2025Accounts Receivable
129.50MEURFY2025 · Dec 31, 2025Inventory
214.00MEURFY2025 · Dec 31, 2025Accounts Payable
248.00MEURFY2025 · Dec 31, 2025Short-term Debt
86.30MEURFY2025 · Dec 31, 2025Long-term Debt
329.30MEURFY2025 · Dec 31, 2025Common Stock (Book)
400.00KEURFY2025 · Dec 31, 2025Retained Earnings
-358.20MEURFY2025 · Dec 31, 2025Total Shareholders' Equity
479.20MEUR531.22M · vs all stocks (USD)
52-Week Low
30.20EURUpdated Oct 29, 202652-Week High
79.90EURUpdated Oct 29, 202652-Week Change
10.38%vs all stocks
Beta
1.31xvs all stocks
50-Day MA
65.21EURUpdated Oct 29, 2026200-Day MA
57.08EURUpdated Oct 29, 2026Avg 10-Day Volume
72.94KSharesUpdated Oct 29, 2026Avg 30-Day Volume
102.73KSharesUpdated Oct 29, 2026Diluted EPS (TTM)
-2.07EURUpdated Oct 29, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.45: safe zoneNotable
Altman Z-Score: 3.45
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $1.77B, above the global median of $1.14BNotable
Market cap (USD): 1,772,808,462.424Global Median: 1,137,180,293.291
Revenue is $3.57B, above the global median of $566.17MNotable
Revenue (USD): 3,566,648,840.947Global Median: 566,172,992
Companies that share the same coordination system — how they create, deliver, or capture value.
Trial Holdings Inc.
Tier 1FlowUnit ReplicationRiskInterface
Dis-Chem Pharmacies Limited
Tier 1FlowUnit ReplicationInterfaceProduction
Prosegur Compañía de Seguridad, S.A.
Tier 1FlowUnit ReplicationRuleProduction
BGF Retail Co. Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Weis Markets Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Shanghai Waigaoqiao Free Trade Zone Development Co., Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Ingles Markets Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Driven Brands Holdings Inc.
Tier 1FlowUnit ReplicationProductionInterface
Laobaixing Pharmacy Chain Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Sally Beauty Holdings Inc.
Tier 1FlowUnit ReplicationInterfaceSenseMaking